IRIS
BONAVITA, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.897
AS - Asia 5.189
NA - Nord America 5.129
SA - Sud America 1.015
AF - Africa 80
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 19.335
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.041
RU - Federazione Russa 2.887
SG - Singapore 1.866
IE - Irlanda 1.394
CN - Cina 1.334
IT - Italia 1.305
HK - Hong Kong 895
BR - Brasile 849
GB - Regno Unito 557
DE - Germania 495
UA - Ucraina 422
KR - Corea 269
VN - Vietnam 253
IN - India 169
SE - Svezia 162
FI - Finlandia 140
TR - Turchia 140
FR - Francia 130
GR - Grecia 120
JP - Giappone 110
AT - Austria 103
AR - Argentina 70
MX - Messico 41
BE - Belgio 40
NL - Olanda 39
CA - Canada 28
EC - Ecuador 26
BD - Bangladesh 23
CO - Colombia 22
ZA - Sudafrica 18
CZ - Repubblica Ceca 17
EG - Egitto 17
ES - Italia 17
IQ - Iraq 17
ID - Indonesia 16
AU - Australia 15
MA - Marocco 15
VE - Venezuela 15
PK - Pakistan 14
PL - Polonia 14
IL - Israele 10
IR - Iran 10
PE - Perù 10
PY - Paraguay 10
UZ - Uzbekistan 9
CH - Svizzera 8
KE - Kenya 7
KZ - Kazakistan 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
LT - Lituania 6
PA - Panama 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
EU - Europa 5
JM - Giamaica 5
RO - Romania 5
UY - Uruguay 5
ET - Etiopia 4
IS - Islanda 4
JO - Giordania 4
LU - Lussemburgo 4
RS - Serbia 4
DZ - Algeria 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
PH - Filippine 3
SN - Senegal 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
HU - Ungheria 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
Totale 19.324
Salva come PNG Salva come JPEG
Città #
Dublin 1.392
Moscow 950
Santa Clara 894
Hong Kong 893
Jacksonville 639
Singapore 624
Chandler 583
Seoul 264
Hefei 260
Princeton 201
Beijing 188
Ann Arbor 160
Roxbury 159
Dallas 147
Medford 147
Bremen 142
Ashburn 127
Bengaluru 127
Boardman 118
Caserta 110
The Dalles 107
Naples 101
Ho Chi Minh City 100
Munich 91
New York 88
Vienna 84
Cambridge 71
São Paulo 66
Milan 65
Wilmington 64
Rome 58
Woodbridge 56
San Mateo 55
Des Moines 45
Los Angeles 45
Nanjing 43
Hanoi 42
Brussels 39
Norwalk 37
Napoli 33
Nuremberg 33
Jinan 29
Redhill 27
Shenyang 24
Helsinki 21
Rio de Janeiro 21
Belo Horizonte 20
Brasília 20
Guangzhou 20
Redwood City 20
Tianjin 20
Falkenstein 18
London 16
San Francisco 16
Hebei 14
Curitiba 13
Lappeenranta 13
Mexico City 13
Mountain View 13
Nanchang 13
Turin 13
Turku 13
Aversa 12
Brooklyn 12
Genoa 12
Hangzhou 12
Lanzhou 12
Padova 12
Tokyo 12
Atlanta 11
Brno 11
Campinas 11
Chicago 11
Düsseldorf 11
Houston 11
Porto Alegre 11
Stockholm 11
Verona 11
Warsaw 11
Busto Arsizio 10
Changsha 10
Da Nang 10
Ercolano 10
Grafing 10
Phoenix 10
Ribeirão Preto 10
Boston 9
Buffalo 9
Salvador 9
Shanghai 9
Taiyuan 9
Tashkent 9
Auburn Hills 8
Frankfurt am Main 8
Guarulhos 8
Haikou 8
Lima 8
Thái Bình 8
West Jordan 8
Bauru 7
Totale 10.206
Salva come PNG Salva come JPEG
Nome #
Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory 605
Spazi di Virchow Robin e sclerosi multipla: studio con risonanza magnetica ad Alto Campo 3 Tesla 233
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study. 152
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus. 150
Default mode network changes in multiple sclerosis: A link between depression and cognitive impairment? 148
Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume 144
Distributed changes in default-mode resting-state connectivity in multiple sclerosis 138
Preliminary data from a study on clinical and neuroradiological correlations between cerebral microbleeds and different subtypes of mild cognitive impairment 132
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis 131
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study. 130
Advantages of QBI in TBSS analyses. 130
Atypical Progressive Multifocal Leukoencephalopathy in a Kidney Transplant Recipient With Improving Symptoms After Immunocompetence Recovery 126
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. 124
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study. 120
A simple measure of cognitive reserve is relevant for cognitive performance in MS patients 120
Fatigue in multiple sclerosis: The contribution of occult white matter damage. 119
BDNF Val66Met polymorphism and brain volumes in multiple sclerosis 110
Depressive symptoms correlate with disability and disease course in multiple sclerosis patients: An Italian multi-center study using the Beck Depression Inventory 110
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 109
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study 109
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients. 109
An exploration of anger phenomenology in multiple sclerosis 107
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 107
Il Ruolo della RM nella definizione morfologica dell'invecchiamento cerebrale. 106
The role of diet in multiple sclerosis: A review 106
Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures 106
Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization 105
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis 105
Telemedicine application to headache: a critical review 105
Aspetti neuroradiologici inusuali in un caso di leucoencefalite multifocale progressiva in paziente non HIV positivo 103
Chronic acquired hepatocerebral degeneration: a case report. 103
Repetitive Transcranial Magnetic Stimulation (rTMS) of Dorsolateral Prefrontal Cortex May Influence Semantic Fluency and Functional Connectivity in Fronto-Parietal Network in Mild Cognitive Impairment (MCI) 103
Is the pathology of posterior cortical atrophy clinically predictable? 99
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate 99
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis 98
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 98
Long-Term Neuromodulatory Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Plasmatic Matrix Metalloproteinases (MMPs) Levels and Visuospatial Abilities in Mild Cognitive Impairment (MCI) 97
INFRATENTORIAL PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN A PATIENT TREATED WITH FLUDARABINE AND RITUXIMAB 97
Treatment of multiple sclerosis with interferon beta in clinical practice: 2-year follow-up data from the South Italy Mobile MRI Project. 97
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic 96
Apolipoprotein E genotype does not influence the progression of multiple sclerosis 95
Sistema somato-sensitivo 95
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells 95
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS. 94
Proton spectroscopic imaging - Principles and clinical applications in neurology 92
Anti-GM1 ganglioside antibodies in Parkinson's disease 92
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study. 92
e-Health and multiple sclerosis: An update 91
Brain atrophy and fatigue in relapsing-remitting multiple sclerosis patients: a 3T study 90
Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent 88
MAlattie infettive (meningiti, encefaliti, infezione da HIV, encefalopatie spongiformi) 88
Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey 88
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study 87
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab 87
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 86
Between-sex variability of resting state functional brain networks in amyotrophic lateral sclerosis (ALS) 86
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 85
Apparently isolated CNS involvement in Erdheim-Chester disease: Case report 85
Diffuse central neuronal involvement in Fabry disease: a proton MRS imaging study 85
Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis 85
Social Media and Multiple Sclerosis in the Posttruth Age. 85
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study 84
Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study. 84
Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 tesla in the delineation of glioblastomas: Preliminary results 84
Prevalence of patient-reported dysphagia in multiple sclerosis patients: An Italian multicenter study (using the DYMUS questionnaire). 84
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study 84
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice. 83
Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations 83
Disability assessment using Google Maps 83
Spettroscopia di risonanza magnetica nelle encefalopatie infantili 82
Brain atrophy and lesion load in a large population of patients with multiple sclerosis. 82
Lack of association between estrogen receptor 1 gene polymorphisms and multiple sclerosis in southern Italy in humans 82
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity 82
Resting-State Functional Correlates of Social Cognition in Multiple Sclerosis: An Explorative Study 82
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 82
Cd19 cell count at baseline predicts b cell repopulation at 6 and 12 months in multiple sclerosis patients treated with ocrelizumab 82
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series 81
Insertion of mutant proteolipid protein results in missorting of myelin proteins 81
Body weight influences pharmacokinetics of levodopa in Parkinson's disease 81
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study 81
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 81
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study 80
MR image segmentation and tissue metabolite contrast in 1H spectroscopic imaging of normal and aging brain 80
Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study 80
Pelvic Floor Dysfunctions and Their Rehabilitation in Multiple Sclerosis 80
Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy. 79
La terapia della sclerosi multipla 79
The Rise of the GRN C157KfsX97 Mutation in Southern Italy: Going Back to the Fall of the Western Roman Empire 79
Systematic Review on the Role of Lobar Cerebral Microbleeds in Cognition 79
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review 78
Spectroscopic imaging of radiation-induced effects in the white matter of glioma patients 78
Functional plasticity of the visual system in multiple sclerosis. 78
Assessing disability and relapses in multiple sclerosis on tele-neurology 78
Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience 78
Paternally inherited case of congenital DM1: Brain MRI and review of literature 77
Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis 77
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting 77
A real-world study of alemtuzumab in a cohort of Italian patients 77
Exploring brain function with magnetic resonance imaging 76
Morphostructural MRI abnormalities related to neuropsychiatric disorders associated to multiple sclerosis. 76
Totale 10.191
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.088
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021659 0 0 0 0 0 26 160 104 16 140 147 66
2021/20221.457 78 53 37 54 428 45 35 46 62 98 95 426
2022/20232.619 280 51 33 175 314 165 4 162 1.276 29 59 71
2023/20241.486 109 46 87 135 411 116 115 38 32 37 107 253
2024/20254.071 18 37 36 157 643 527 488 336 620 591 361 257
2025/20266.807 608 892 941 810 1.421 2.135 0 0 0 0 0 0
Totale 19.825